MannKind Corp Executive Compensation Details Revealed
Ticker: MNKD · Form: DEF 14A · Filed: Apr 1, 2025 · CIK: 899460
| Field | Detail |
|---|---|
| Company | Mannkind CORP (MNKD) |
| Form Type | DEF 14A |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: MNKD
TL;DR
MannKind's proxy statement is out, showing exec pay details for 2024. Focus on equity awards.
AI Summary
MannKind Corp filed its DEF 14A on April 1, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on stock options and changes in the fair value of equity awards granted to both executive and non-executive personnel. Specific dollar amounts and dates related to these awards are provided within the compensation tables.
Why It Matters
This filing provides transparency into how MannKind Corp compensates its top executives, which can influence investor decisions and perceptions of the company's financial health and management strategy.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the details of executive compensation can sometimes reveal underlying financial health or strategic priorities that may impact stock performance.
Key Numbers
- 2024 — Fiscal Year (The primary year for which executive compensation data is reported.)
- 2025 — Filing Year (The year the DEF 14A filing was made.)
Key Players & Entities
- MannKind Corp (company) — Filer of the DEF 14A
- 0000899460 (company) — Central Index Key for MannKind Corp
- 2024-12-31 (date) — Fiscal year end for compensation details
- 20250401 (date) — Filing date of the DEF 14A
FAQ
What is the total reported compensation for the named executive officers in 2024?
The filing provides detailed breakdowns of compensation components such as salary, stock awards, option awards, and non-equity incentive plan compensation for named executive officers, but a single total figure requires aggregation from the Summary Compensation Table.
What were the key performance metrics tied to incentive compensation for 2024?
The filing indicates that incentive compensation is tied to performance, but specific metrics and targets for 2024 would be detailed within the Compensation Discussion and Analysis section, which is not fully provided in the excerpt.
How has the fair value of equity awards changed from prior years to 2024?
The filing includes sections detailing the 'Change in Fair Value of Equity Awards Granted in Prior Years' and 'Year-End Fair Value of Equity Awards Granted in Covered Year Outstanding and Unvested,' indicating changes in valuation for awards granted in previous years and those granted in 2024.
Are there any new equity awards granted in 2024?
Yes, the filing references 'Equity Awards in Summary Compensation Table for Applicable Year' and 'Year-End Fair Value of Equity Awards Granted in Covered Year Outstanding and Unvested' for 2024, indicating new awards were granted.
What is the company's primary business sector?
MannKind Corp operates in the 'Pharmaceutical Preparations' sector, with SIC code 2834.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 1, 2025 regarding MANNKIND CORP (MNKD).